Our results on the efficacy of penfluridol in adult GBM cells with IDH1 mutations are supported by findings from other laboratories, which shows that IDH1 mutation is associated with prolonged overall survival and better efficacy of temozolomide [24]. Here, IDH1 is linked to glioblastoma.